Inverness Counsel’s Exact Sciences EXAS Stock Holding History

Inverness Counsel’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-2,131	Closed	-$252K	–	119
2019 Q2	$252K	Buy	+2,131	New	+$215K	0.01%	100

Other funds holding EXAS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return

Inverness Counsel's EXAS Position: Q3 2019 in Review

Inverness Counsel sold out of Exact Sciences (EXAS) in Q3 2019, closing a stake of 2,131 shares — an estimated $252K sold.

Inverness Counsel first reported a position in EXAS in Q2 2019 and held it in 1 quarter. The position peaked at $252K in Q2 2019. 475 funds tracked by Wall St. Rank hold EXAS as of Q3 2019.

Inverness Counsel reported no remaining Exact Sciences position as of Q3 2019 after selling out during the quarter.
Inverness Counsel sold 2,131 Exact Sciences shares in Q3 2019, an estimated $252K.
Inverness Counsel first reported a position in Exact Sciences in Q2 2019 and held it in 1 quarter.
Inverness Counsel's Exact Sciences position peaked at $252K in Q2 2019.
475 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2019.

Based on Inverness Counsel's 13F filing for Q3 2019, filed 12 Nov 2019.